Boardroom Alpha
Boardroom Alpha
TILE · Current Report (Form 8-K) · Filed December 3, 2025

Interface Inc — Current Report (Form 8-K)

Form
8-K
Filed
December 3, 2025
Period
Dec 3, 2025
Ticker
TILE
Accession
0000715787-25-000035
Boardroom Alpha · Filing insights

Interface adds a $170M term loan, extends facility to 2030, and redeems the 2028 notes.

About Interface Inc
Market cap
$1.7B
1Y TSR
+39.6%
3Y TSR
+52.6%
Board grade
B+
Sector
Basic Materials
CEO
Laurel Hurd
Last annual meeting: May 19, 2026 · View full Interface Inc profile →
tile-20251203

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C.  20549
                                   

FORM 8-K
                                   

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934

Date of Report (Date of Earliest Event Reported):  December 03, 2025
                                   

INTERFACE INC
__________________
           
(Exact name of Registrant as Specified in its Charter)
Georgia 001-33994 58-1451243
(State or other Jurisdiction of Incorporation or Organization) (Commission File
Number)
 (IRS Employer
Identification No.)
1280 West Peachtree Street NWAtlantaGeorgia30309
(Address of principal executive offices)(Zip code)

Registrant’s telephone number, including area code:  (770) 437-6800

Not Applicable 
(Former name or former address, if changed since last report)
Securities Registered Pursuant to Section 12(b) of the Act:
Title of Each ClassTrading Symbol(s)Name of Each Exchange on Which Registered
Common Stock, $0.10 Par Value Per ShareTILENasdaq Global Select Market

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company      
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.   ¨





ITEM 1.01     ENTRY INTO A MATERIAL DEFINITIVE AGREEMENT


Entry into Third Amended and Restated Syndicated Facility Agreement

On December 3, 2025, Interface, Inc. (“the Company”) entered into the Third Amended and Restated Syndicated Facility Agreement (the “Agreement”) with certain of its wholly owned foreign subsidiaries as co-borrowers (together with the Company, collectively, the “Borrowers”), its material domestic subsidiaries as guarantors, Bank of America, N.A. as administrative agent and lender, and the other lenders signatory thereto. The purpose of the Agreement is to amend and restate that certain Second Amended and Restated Syndicated Facility Agreement, dated as of August 7, 2018, as subsequently amended. The key changes from the prior agreement include, but are not limited to, the following:

(a) amending the interest rates applicable to the loans thereunder as follows: interest on Base Rate loans is charged at varying rates computed by applying a margin ranging from 0.125% to 1.00% over the Base Rate (as defined in the Agreement, the greater of the Federal Funds Rate plus a margin, the prime rate or the Secured Overnight Financing Rate ("SOFR") plus a margin), depending on the Company’s consolidated net leverage ratio (as defined in the Agreement) as of the most recently completed fiscal quarter. Interest on SOFR-based and alternative currency loans is charged at varying rates computed by applying a margin ranging from 1.125% to 2.00% over the applicable SOFR rate or alternative currency rate, depending on the Company’s consolidated net leverage ratio as of the most recently completed fiscal quarter;

(b) extending the maturity date of the revolving and term loan credit facilities thereunder from October 14, 2027 to December 3, 2030;

(c) adding a new term loan facility in an aggregate principal amount of $170 million (the “Term Loan”);

(d) reducing the revolving credit facility from $300 million to $250 million; and

(e) reducing the maximum unused facility commitment fee to 0.30%.

The Term Loan was fully drawn at closing and the net proceeds therefrom applied to the redemption of the Notes (as defined below) described in Item 1.02 below. Quarterly amortization payments are required for Term Loan borrowings, due on the last day of the calendar quarter. Giving effect to the Term Loan draw, the Borrowers were indebted under the Agreement in the approximate amount of $205 million at closing. The applicable weighted average interest rate at close is estimated to be 5.24%.

The Company pays a commitment fee ranging from 0.20% to 0.30% per annum (depending on the Company’s consolidated net leverage ratio as of the most recently completed fiscal quarter) on the unused portion of the available loans under the Agreement.

The Agreement contains standard and customary covenants for agreements of this type, including various reporting, affirmative and negative covenants. Among other things, these covenants limit the Borrowers’ ability to: create or incur liens on assets; make acquisitions of or investments in businesses (in excess of certain specified amounts); engage in any material line of business substantially different from the Company’s current lines of business; incur indebtedness or contingent obligations; sell or dispose of assets (in excess of certain specified amounts); pay dividends or repurchase Company stock (in excess of certain specified amounts); repay other indebtedness prior to maturity unless certain conditions are met; and enter into sale and leaseback transactions.

The Agreement also requires compliance with the following financial covenants as of the end of each fiscal quarter, based on the consolidated results for the four fiscal quarters most recently ended:

Consolidated Secured Net Leverage Ratio: Must be no greater than 3.00:1.00.
Consolidated Interest Coverage Ratio: Must be no less than 2.25:1.00.





If the Borrowers breach or fail to perform any of the affirmative or negative covenants under the Agreement, or if other specified events occur (such as a bankruptcy or similar event or a change of control of the Company or certain subsidiaries, or if the Borrowers breach or fail to perform any covenant or agreement contained in any instrument relating to any other indebtedness exceeding $25 million), after giving effect to any applicable notice and right to cure provisions, an event of default will exist. If an event of default exists and is continuing, the lenders’ administrative agent may, and upon the written request of a specified percentage of the lender group shall: declare all commitments of the lenders under the Agreement terminated; declare all amounts outstanding or accrued thereunder immediately due and payable; and exercise other rights and remedies available to them under the agreement and applicable law.

The Agreement is secured by substantially all of the assets of the Company and its domestic subsidiaries (subject to exceptions for certain immaterial subsidiaries), including all of the stock of its domestic subsidiaries, up to 65% of the stock of certain material foreign subsidiaries entitled to vote and 100% of the stock of certain material foreign subsidiaries directly owned by any domestic subsidiaries not entitled to vote. If an event of default occurs under the Agreement, the lenders’ administrative agent may, upon the request of a specified percentage of lenders, exercise remedies with respect to the collateral, including, in some instances, foreclosing mortgages on real estate assets, taking possession of or selling personal property assets, collecting accounts receivable, or exercising proxies to take control of the pledged stock of domestic and certain material foreign subsidiaries.

The foregoing summary of the Agreement is qualified in its entirety by reference to the full text of such agreement, which is filed as Exhibit 10.1 to this Current Report on Form 8-K and incorporated by reference herein.


ITEM 1.02 TERMINATION OF A MATERIAL DEFINITIVE AGREEMENT.

Redemption of Notes and Satisfaction and Discharge of Indenture

As previously reported, on November 18, 2025, the Company delivered a notice of conditional redemption for all of its $300 million outstanding principal amount of 5.50% Senior Notes due 2028 (the “Notes”). The Notes were fully redeemed on December 3, 2025 using a combination of the net proceeds from the Term Loan and the Company’s available cash on hand.

In connection the redemption of the Notes, the Indenture governing the Notes dated as of November 17, 2020 by and among the Company, as issuer, the guarantors party thereto, and Regions Bank, as trustee (the “Indenture”), was satisfied and discharged, and consequently the Company’s and the guarantors’ obligations under the Indenture and the Notes is terminated, subject to certain customary surviving obligations.

The foregoing summary of the consequences of the redemption of the Notes and satisfaction and discharge of the Indenture is qualified in its entirety by reference to the full text of the Indenture, and Section 8.01 thereto in particular, which is incorporated by reference from Exhibit 4.1 to the Company's Current Report on Form 8-K filed on November 18, 2020 and included as Exhibit 10.2 to this Current Report on Form 8-K and incorporated by reference herein.


ITEM 2.03 CREATION OF A DIRECT FINANCIAL OBLIGATION OR AN OBLIGATION UNDER AN OFF-BALANCE SHEET ARRANGEMENT OF A REGISTRANT.

The disclosure under Item 1.01 of this Current Report on Form 8-K related to the Agreement is incorporated by reference in response to this Item 2.03.









ITEM 9.01 FINANCIAL STATEMENTS AND EXHIBITS.


(d) Exhibits.
Exhibit No.Description
10.1*
10.2
104Cover Page Interactive Data File (embedded within the Inline XBRL document)
*Schedules and certain exhibits have been omitted pursuant to Item 601(a)(5) of Regulation S-K. The Company undertakes to furnish supplemental copies of any of the omitted documents upon request by the Securities & Exchange Commission.


















SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 
 INTERFACE, INC.
  
  
By:       /s/ David B. Foshee
 David B. Foshee
 Vice President
Date:  December 3, 2025 

From this filing to the file

Every SEC filing, parsed structured.

Boardroom Alpha indexes every 8-K, 10-K, 10-Q, and proxy back to 2000 — vote tabulations, comp tables, red flags, insider transactions, all queryable the day they hit EDGAR.

Independent — issuer-pays-free, ideology-free, U.S.-owned.

More filings

Other filings from Interface Inc (TILE)

Reference

Frequently asked questions

When did Interface Inc file this 8-K?
Interface Inc (TILE) filed this Current Report (Form 8-K) with the SEC on December 3, 2025. The accession number assigned by EDGAR is 0000715787-25-000035.
What does an 8-K disclose?
Form 8-K is the SEC's current-report form, used to disclose material events between periodic reports (10-K / 10-Q). Triggers include CEO/CFO departures, acquisitions, bankruptcies, earnings releases, auditor changes, changes in fiscal year, and amendments to corporate governance. Each 8-K is keyed to one or more Item numbers (1.01 through 9.01).
What is the key takeaway from this filing?
Interface adds a $170M term loan, extends facility to 2030, and redeems the 2028 notes. This is Boardroom Alpha's one-line summary of the current report; see the full filing text above for the formal disclosure.
What Item codes does an 8-K cover?
An 8-K's Item codes (1.01 through 9.01) specify what kind of event is being disclosed — e.g. Item 1.01 for entering a material agreement, Item 5.02 for departure/election of directors and executive officers, Item 8.01 for other events. The Item codes for this 8-K appear in the filing text above.
Where can I find Interface Inc's prior current reports on EDGAR?
The SEC EDGAR browser lists every 8-K Interface Inc has filed under CIK 715787, sortable by date. Use the "View on SEC EDGAR" link in the page header, or browse directly via https://www.sec.gov/cgi-bin/browse-edgar.
Disclaimer

The opinions and information contained herein have been obtained or derived from sources believed to be reliable, but Boardroom Alpha cannot guarantee its accuracy and completeness, and that of the opinions based thereon.

This report contains opinions and is provided for informational purposes only – it does not constitute investment, legal or tax advice. You should not rely solely upon the research herein for purposes of transacting securities or other investments, and you are encouraged to conduct your own research and due diligence, and to seek the advice of a qualified securities professional before you make any investment.

None of the information contained in this report constitutes, or is intended to constitute a recommendation by Boardroom Alpha of any particular security or trading strategy or a determination by Boardroom Alpha that any security or trading strategy is suitable for any specific person. To the extent any of the information contained herein may be deemed to be investment advice, such information is impersonal and not tailored to the investment needs of any specific person.

No representation or warranty, expressed or implied, is made on behalf of Boardroom Alpha as to the accuracy or completeness of the information contained herein. Boardroom Alpha does not accept any liability for any direct, indirect or consequential loss or damage suffered by any person as a result of relying on all or any part of this research and any liability is expressly disclaimed.

Full disclaimer